[Research Report] The Metagenomics market size was projected to grow from US$ 165.8 million in 2018 to US$ 314.3 million by 2027; it is further estimated to record a CAGR of 7.7% from 2019–2027.
Market Insights and Analyst View:
Metagenomics is defined as the study of the metagenome, which is the collective genome of microorganisms. The microorganisms are collected from environmental samples, and studies are conducted to provide information on a specific environment's microbial diversity and ecology. Microorganisms are studied through the shotgun metagenomics technology/ technique used to extract the DNA from the environmental sample and sequence the small fragments. Metagenomics is a rising and vibrant field that has appropriated the tools used for standard genomics and applied them to study entire communities of microbes. This requires no need to isolate and culture the individual microbial species. Metagenomics primarily aims to study and identify microbial species' genes and metabolic pathways.
The reduced metagenomic sequencing cost and increasing genome projects will likely contribute to the metagenomics market's growth. The rising prevalence of chronic and infectious diseases such as cancer, chronic liver disease, and others may increase the adoption of metagenomics for timely diagnosis. The increasing adoption of metagenomics in clinical diagnostics propels the market growth. Metagenomics assists in disease detection in crops and livestock by exploring the interaction between plants and microbes, which might drive the growth in this niche. Thus, the abovementioned factors are likely to propel the global metagenomics market size.
Growth Drivers and Challenges:
Metagenomic is a field that combines various important molecular technologies and enables scientists to investigate microorganisms more deeply. The technology enables to unlock the vast biotechnological potentials that are held inside the microorganisms. Metagenomics helps to identify microorganism irrespective of whether they can be cultured or not. The analysis can be done from the genomic data obtained directly from an environmental sample that provides information about the species existing and it also allow the extraction of information regarding the functionality of microbial communities in their natural habitat.
In addition, the metagenomics also holds the capabilities in the food and pharmaceutical industries. For instance, metagenomics can be useful for the identification of enzymes with desirable technological properties. This enables to relate the capable of catalysing novel reactions which may be difficult or expensive to produce. Moreover, it enables to identify the functions under a wide range of environmental conditions encountered in food and pharmaceutical processing cycles including extreme conditions of temperature, pH, osmolarity and others.
Furthermore, the biotechnological application from metagenomics is likely to foster by the pursuit of fundamental ecological studies and focused screens for bioprospecting. Metagenomics has contributed to the discovery of antibiotics and industrial enzymes from cultured microorganisms. For instance, the discovery of streptomycin and other bacterial antibiotics bounced from very basic studies of metagenomics.
Therefore, owing to the advantages of the metagenomics for the application in biotechnologies are likely to boost the growth of the metagenomics market in the forecast years.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Metagenomics Market: Strategic Insights
Market Size Value in US$ 165.8 million in 2018 Market Size Value by US$ 314.3 million by 2027 Growth rate CAGR of 7.7% from 2019 to 2027 Forecast Period 2018 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Metagenomics Market: Strategic Insights
| Market Size Value in | US$ 165.8 million in 2018 |
| Market Size Value by | US$ 314.3 million by 2027 |
| Growth rate | CAGR of 7.7% from 2019 to 2027 |
| Forecast Period | 2018 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “Global Metagenomics Market” is segmented based on product, application, and geography. The metagenomics market by product is categorized into instruments & software and consumables. The market for metagenomics is majorly driven by consumables, as there is large requirement of consumables and kits during the research process.
The application segment of the metagenomics market is broadly segmented into clinical diagnostic, drug discovery metagenomics and others. The other applications of the metagenomics services includes the identification of the innovative biocatalysts, discovery of new antibiotics, personalized medicine and others.
The metagenomics market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The product segment of the metagenomics market is broadly segmented into instruments & software and consumables. The market players in the market are offering diverse portfolio for metagenomics to the researchers for conduction innovations in the technologies.
The rise in the metagenomics studies is leading to the growth of the metagenomics product, platforms and services. The companies such as Illumina, Inc, ThermoFisher Scientific Inc, Qiagen, Perkin Elmer among others are major players in the market for the metagenomics. The consumables is the largest segment among the product segment in the metagenomics market in 2018 and is also anticipated to hold the largest market in the year 2027.
The research also requires the consumables and kits in large quantity and there are various market players that offers reagents kits and other consumables that are required for the metagenomics. For instance, Illumina inc., offers MiSeq v3 Reagents Kits, MiSeq v2 Reagents Kits, NextSeq 500/550 v2 Kits, HiSeq 4000 SBS Kit and PE Cluster Kit. Perkin Elmer Inc offers NEXTflex library preparation kits which include NEXTflex 16S and 18S Amplicon-Seq Kits. Similarly, Merck KGaA offers broad array of qPCR kits and probes for all detection chemistries and all instrument platforms. The portfolio includes standard qPCR kits, Capillary tube qPCR kits, high-throughput qPCR kits and one-step qRT-PCR kits among the others.
Metagenomics market, by Product – 2018 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Regional Analysis:
Based on geography, the metagenomics market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In terms of revenue, North America dominated the metagenomics market share. The North America metagenomics market has been segmented into US, Canada, and Mexico. The US holds the largest share of the North American metagenomics market. The growth in North America is characterized by increase in the demand of the metagenomics, increasing funding for the metagenomics, and the rise in the demand for the precision medicine to treat various diseases.
Further, presence of major market players in the US and increasing number of metagenomics project is likely to drive the US metagenomics market. The major players headquartered in the US are also focused towards developing innovative and novel products and bringing them into market, which is also one of the major factors driving the growth of US in the global metagenomics market. Moreover, the companies are significantly investing under research and development to come-up with medical products that are derived from natural microbial sources. For instance, in August 2018, Genentech and Lodo initiated a US$ 1 Bn project to develop unique, natural products from the microbial DNA found in soil. Under the collaboration, Genentech will use Lodo’s metagenome-prospecting platform to identify novel small molecules with the potential for treating disease. Thus, the presence of major market players will likely contribute to the growth of the US metagenomics market size.
Additionally, Asia Pacific is fastest growing market for metagenomics. China, India and Japan are three major contributors to the growth of the market which is driven by increasing investments by the governments of the respective countries in the region, rise in the programs such as in India and the extensive research in respective countries. The region is anticipated to be the fastest growing region owing to the above-mentioned factors and these factors are to likely drive the metagenomics market in the forecast period.
Further, Europe metagenomics market includes the consolidated markets for France, Germany, the United Kingdom (UK), Spain, Italy, and the Rest of Europe. Europe occupies the second position in the global metagenomics market and is expected to register a robust growth rate over the forecast period. Government and private funding for metagenomics, launch of innovative technologies and metagenomics-based products and diagnostic tests as well as increase in various research for programs for the metagenomics are likely to be the major factors driving the growth of this market in the European region.
Middle East and Africa consists of three major countries namely United Arab Emirates (UAE), Saudi Arabia and South Africa. UAE is the largest market for metagenomics. The market is driven by extensive research programs undertaken by a number of research institutes and availability of infrastructure and facilities for research in UAE and Saudi Arabia. The support by the government in these countries are likely to drive the growth of the market. On the other hand, the growth of the metagenomics market in South Africa is likely to grow significantly due to the extensive research and initiatives by the institutes and government bodies to enhance the biotechnology field.
The South and Central America region broadly describes about the country Brazil. The growth of the metagenomics market in the country is led by the excessive research and studies for the metagenomics. In addition, the universities in the Latin America are collaborating to increase the studies that are related to the research field. Thus, owing to these factors the metagenomics market in the region is likely to grow at a speedy rate and is anticipated to increase its market share in the global market of the metagenomics in the coming forecast period.
Industry Developments and Future Opportunities:
Some of the activities undertaken by the company, which have promoted its growth are product launches, expansion, and others. Such activities are the major market players likely to boost the global metagenomics market. Various initiatives taken by key players operating in the global metagenomics market are listed below:
- In June 2023, Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, received funding of $35 million which will be used to commercialize the company’s mNGS-based infectious disease test. This test was developed by infectious disease experts ofcc the University of California San Francisco (UCSF) Center for Next-Gen Precision Diagnostics
- In June 2022, Oxford Nanopore released a novel protocol for the rapid metagenomic characterization of DNA and RNA viruses. This protocol illustrates a simple metagenomic workflow that can be used to discover DNA and RNA viruses. This protocol has been adopted in human clinical samples to identify the pathogen known as the monkeypox virus.
- In September 2022, Illumina, Inc. launched the NovaSeq X series production-scale sequencers, which has the capability of generating more than 20,000 whole genomes per year (which is 2.5 times more the throughput of prior sequencers from Illumina).
- In September 2021, AstraZeneca and Thermo Fisher Scientific, Inc. together developed an NGS-based companion diagnostic product. The collaboration was focused on marketing the NGS-based diagnostic products in Russia.
Covid-19 Impact:
Across the various healthcare sectors, the effect of a pandemic could be felt, which resulted in various changes in the health care industry. Scientists across the globe are collaborating to generate and distribute genomic sequence data information which could be applied to disease diagnosis and control efforts. The US is increasing its ability to track coronavirus mutations with genomic sequencing techniques as reserchers warned that new variants increase the number of cases and hospitalizations. For instance, the US ranked 43rd in genome sequencing project by sequencing 3% of the sample, according to the GISAID Initiative, a global genome sequencing database project. The sequencing of the genome can help in the fight against Covid-19 and its newly emerging variants.
Moreover, in April 2020, genome Canada launched CanCOGeN, the Canadian COVID Genomics Network, an initiative backed with USD 40 million funding. The role of CanCOGeN is to establish a coordinated pan-Canadian, cross-agency network for large-scale SARS-CoV-2 and human host sequencing in order to track viral origin, spread and evolution, to characterize the role of human genetics in COVID-19 disease and to inform time-sensitive critical decision making relevant to health authorities across Canada during the pandemic. All such developments will add to the future demand for the metagenomics market.
Competitive Landscape and Key Companies:
Some of the prominent players operating in the global metagenomics market include Merck KGaA, Thermos Fisher Scientific Inc., Qiagen, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Perkin Elmer, Inc., Illumina Inc. and F. Hoffmann-La Roche Ltd. among others. These companies have been implementing various inorganic developments that have bought about dynamic improvements in the metagenomics market due to the involvement of major players which has led to availability of better services and products in the market. Thus, allowing them to serve a large set of customers and subsequently increase their market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global metagenomics market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
The most lucrative region is North America, growing at CAGR of 8%.
Metagenomics can be defined as the study of the metagenome, which is collective genome of microorganisms. The microorganisms’ samples are collected from environmental and the studies are performed to provide information on the microbial diversity and ecology of a specific environment. The study of microorganism is conducted through the shotgun technique, which is used to extract the DNA from the environmental sample and sequence the small fragments.
High capital cost of metagenomics is the major factor hindering the market growth.
The growth of the global metagenomics market is attributed to the increasing venture capital investments, advantages of metagenomics in biotechnology and industrial application of metagenomics.
TABLE OF CONTENTS
1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. GLOBAL METAGENOMICS MARKET – KEY TAKEAWAYS
3. GLOBAL METAGENOMICS MARKET – MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 Global Metagenomics Market – By Product
3.2.2 Global Metagenomics Market – By Application
3.2.3 Global Metagenomics Market – By Geography
3.3 PEST ANALYSIS
3.3.1 North America – PEST Analysis
3.3.2 Europe– PEST Analysis
3.3.3 Asia Pacific– PEST Analysis
3.3.4 Middle East And Africa– PEST Analysis
3.3.5 South and Central America – PEST Analysis
4. GLOBAL METAGENOMICS MARKET – KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Increasing Venture Capital Investments
4.1.2 Advantages of Metagenomics in Biotechnology
4.1.3 Industrial Applications of Metagenomics
4.2 KEY MARKET RESTRAINTS
4.2.1 High Capital Costs Of Metagenomics
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Usage of Metagenomics for Precision Medicine
4.3.2 Emerging Nations
4.4 KEY MARKET TRENDS
4.4.1 Extensive Set Of Molecular-Based Approaches
4.5 IMPACT ANALYSIS
5. METAGENOMICS MARKET – GLOBAL ANALYSIS
5.1 GLOBAL METAGENOMICS MARKET REVENUE FORECASTS AND ANALYSIS
5.2 GLOBAL METAGENOMICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
5.3 MARKET POSITIONING
5.4 PERFORMANCE OF KEY PLAYERS
5.4.1 Illumina, Inc.
5.4.2 Qiagen
5.5 EXPERT OPINIONS
6. GLOBAL METAGENOMICS MARKET ANALYSIS – BY PRODUCT
6.1 OVERVIEW
6.2 GLOBAL METAGENOMICS MARKET, BY PRODUCT, 2018 & 2027 (%)
6.3 INSTRUMENTS & SOFTWARE MARKET
6.3.1 Overview
6.3.2 Global Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 CONSUMABLES MARKET
6.4.1 Overview
6.4.2 Global Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
7. GLOBAL METAGENOMICS MARKET ANALYSIS – BY APPLICATION
7.1 OVERVIEW
7.2 GLOBAL METAGENOMICS MARKET, BY APPLICATION, 2018 & 2027 (%)
7.3 CLINICAL DIAGNOSTIC MARKET
7.3.1 Overview
7.3.2 Global Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 DRUG DISCOVERY METAGENOMICS MARKET
7.4.1 Overview
7.4.2 Global Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 OTHERS MARKET
7.5.1 Overview
7.5.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
8.1 OVERVIEW
8.2 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
8.4 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
8.5 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
8.6 US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.1 US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.2 US Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.6.3 US Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.7 CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7.1 Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Canada Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.3 Canada Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.8 MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.1 Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.3 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
9.1 OVERVIEW
9.2 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.3 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
9.4 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
9.5 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
9.6 UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.6.1 UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
9.6.2 UK Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.6.3 UK Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.7 GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.7.1 Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
9.7.2 Germany Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.7.3 Germany Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.8 FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.8.1 France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
9.8.2 France Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.8.3 France Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 70
10.1 OVERVIEW
10.2 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.3 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
10.4 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
10.5 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
10.6 CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.6.1 China Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.2 China Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.3 China Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.7 JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.7.1 Japan Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.2 Japan Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.3 Japan Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.8 INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.8.1 India Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2 India Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.3 India Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
11.1 OVERVIEW
11.2 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.3 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
11.4 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
11.5 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
11.6 UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.6.1 UAE Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.2 UAE Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.6.3 UAE Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.7 SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.7.1 Saudi Arabia Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.7.2 Saudi Arabia Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.7.3 Saudi Arabia Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.8 SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.8.1 South Africa Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.8.2 South Africa Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.8.3 South Africa Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
12. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
12.1 OVERVIEW
12.2 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.3 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
12.4 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
12.5 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
12.6 BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.6.1 Brazil Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
12.6.2 Brazil Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
12.6.3 Brazil Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
13. METAGENOMICS MARKET –INDUSTRY LANDSCAPE
13.1 OVERVIEW
13.2 GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
13.3 ORGANIC DEVELOPMENTS
13.3.1 Overview
13.4 ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
13.5 PRODUCT LAUNCH
13.5.1 Recent Product Launch By Players In The Metagenomics Market
13.6 PRODUCT APPROVAL
13.6.1 Recent Product Approval By Players In The Metagenomics Market
13.7 EXPANSION & OTHERS
13.7.1 The Metagenomics Market By Expansion & Other Growth Strategies
13.8 INORGANIC DEVELOPMENTS
13.8.1 Overview
13.9 INORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
13.10 ACQUISITIONS
13.10.1 Acquisitions By Players In The Metagenomics Market
13.11 AGREEMENTS
13.11.1 The Metagenomics Market By Agreements
13.12 PARTNERSHIP & COLLABORATION
13.12.1 Partnership By Players In The Metagenomics Market
14. METAGENOMICS MARKET–KEY COMPANY PROFILES
14.1 MERCK KGAA
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 THERMO FISHER SCIENTIFIC, INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Information
14.2.4 Product Portfolio
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 AGILENT TECHNOLOGIES, INC.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 QIAGEN
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES, INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Information
14.5.4 Product Portfolio
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 PERKIN ELMER, INC.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ILLUMINA, INC.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 OXFORD NANOPORE TECHNOLOGIES LTD.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product & Services Portfolio
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 PACIFIC BIOSCIENCE OF CALIFORNIA, INC.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product & Services Portfolio
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 ABOUT THE INSIGHT PARTNERS
15.2 GLOSSARY OF TERMS
15.3 METHODOLOGY
15.3.1 Coverage
15.3.2 Secondary Research
15.3.3 Primary Research
LIST OF TABLES
TABLE 1. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 2. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 3. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 4. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 5. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 6. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 7. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 8. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 9. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 10. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 11. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 12. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 13. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 14. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 15. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 16. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 17. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 18. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 19. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 20. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 21. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 22. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 23. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 24. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 25. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 26. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 27. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 28. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 29. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 30. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 31. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 32. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 33. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 34. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 35. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 36. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 37. RECENT PRODUCT LAUNCH IN THE METAGENOMICS MARKET
TABLE 38. RECENT PRODUCT APPROVAL AND ENHANCEMENTS IN THE METAGENOMICS MARKET
TABLE 39. THE METAGENOMICS MARKET BY EXANSION & OTHERS STRATEGIES
TABLE 40. ACQUISITIONS IN THE METAGENOMICS MARKET
TABLE 41. THE METAGENOMICS MARKET BY AGREEMENTS
TABLE 42. PARTNERSHIP IN THE METAGENOMICS MARKET
TABLE 43. GLOSSARY OF TERMS, METAGENOMICS MARKET
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC METAGENOMICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027
FIGURE 2. GLOBAL METAGENOMICS MARKET BY PRODUCT, MARKET SHARE (%), 2018
FIGURE 3. GLOBAL METAGENOMICS MARKET BY APPLICATION, MARKET SHARE (%), 2018
FIGURE 4. METAGENOMICS MARKET SEGMENTATION
FIGURE 5. METAGENOMICS SEGMENTATION, BY REGION
FIGURE 6. NORTH AMERICA PEST ANALYSIS
FIGURE 7. EUROPE PEST ANALYSIS
FIGURE 8. ASIA PACIFIC PEST ANALYSIS
FIGURE 9. MIDDLE EAST AND AFRICA PEST ANALYSIS
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
FIGURE 11. METAGENOMICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 12. GLOBAL METAGENOMICS MARKET – REVENUE FORECASTS AND ANALYSIS – 2018- 2027
FIGURE 13. GLOBAL METAGENOMICS MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2018- 2027
FIGURE 14. GLOBAL METAGENOMICS MARKET BY PRODUCT, 2018 & 2027 (%)
FIGURE 15. GLOBAL INSTRUMENTS & SOFTWARE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 16. GLOBAL CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. GLOBAL METAGENOMICS MARKET BY APPLICATION, 2018 & 2027 (%)
FIGURE 18. GLOBAL CLINICAL DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. GLOBAL DRUG DISCOVERY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 20. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. NORTH AMERICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 22. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 24. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 27. EUROPE METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 28. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 29. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 30. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 31. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 32. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 33. ASIA PACIFIC METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 34. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 35. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 36. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 37. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 38. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 39. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 40. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 41. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 42. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 43. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 44. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 45. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 46. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 47. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 48. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 49. GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
FIGURE 50. ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
FIGURE 51. INORGANIC DEVELOPMENTS IN THE METAGENOMICS MARKET, 2015-2018
The List of Companies
1. Merck KGaA
2. Thermo Fisher Scientific Inc.
3. Agilent Technologies
4. Qiagen
5. Bio-Rad Laboratories, Inc.
6. Perkinelmer Inc.
7. Illumina Inc.
8. F Hoffman-La Roche Ltd.
9. Oxford Nanopore Technologies Ltd.
10. Pacific Bioscience of California, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Metagenomics Market
Jan 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jan 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jan 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jan 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Jan 2019